But the effect is not confined to any particular GLP-1 medication and can also arise from other interventions that can result in significant weight loss
[DOI] [PubMed] [Google Scholar] 21.Campos RV, Lee YC, Drucker DJ
Works well for many patients, especially those new to GLP-1 therapy
The human body actively resists extreme caloric restriction by slowing the basal metabolic rate and increasing ghrelin production, making long-term adherence nearly impossible for the average patient
A meta-analysis showed that sulfonylurea use is associated with an increased risk of HCC, while GLP-1RAs can lower the risk of HCC (Wang et al., 2024)
Because Truveta Data provides the most complete, timely, and clean de-identified EHR data, including full patient medical records, notes, and images, linked with claims, SDOH, and mortality data for more than 100 million patients across the US, we can show the latest trends in these medications